The store will not work correctly when cookies are disabled.
3-(4-Chlorobenzyl)-5-(3-methoxyphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7(4H)-one
ID: ALA4564110
PubChem CID: 70937737
Max Phase: Preclinical
Molecular Formula: C21H18ClN3O2
Molecular Weight: 379.85
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2cc(=O)n3nc(C)c(Cc4ccc(Cl)cc4)c3[nH]2)cc1
Standard InChI: InChI=1S/C21H18ClN3O2/c1-13-18(11-14-3-7-16(22)8-4-14)21-23-19(12-20(26)25(21)24-13)15-5-9-17(27-2)10-6-15/h3-10,12,23H,11H2,1-2H3
Standard InChI Key: MJASFJWUMZDVEP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
31.6308 -5.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6290 -4.0237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1432 -5.5046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9228 -5.2521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9225 -4.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1418 -4.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6623 -4.8455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1370 -3.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6228 -6.4756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3376 -4.4290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3425 -5.2522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0426 -4.0158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7525 -4.4226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7367 -2.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0352 -3.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4520 -3.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4538 -4.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8411 -4.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4271 -2.9510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4247 -2.1308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7156 -1.7223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0059 -2.1328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0096 -2.9562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7192 -3.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2934 -1.7211 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.1557 -2.7776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8615 -3.1862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
1 11 1 0
10 2 1 0
2 5 1 0
4 5 1 0
3 4 1 0
5 6 2 0
6 7 1 0
7 3 2 0
6 8 1 0
1 9 2 0
10 11 2 0
10 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 2 0
7 18 1 0
8 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
16 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.85 | Molecular Weight (Monoisotopic): 379.1088 | AlogP: 4.25 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.34 | CX Basic pKa: 0.58 | CX LogP: 4.07 | CX LogD: 4.07 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.58 | Np Likeness Score: -1.10 |
References
1. (2012) Heterocyclic compounds for the inhibition of pask, |